Literature DB >> 21183660

Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury.

Kolenkode B Kannan1, Iriana Colorado, Diego Reino, David Palange, Qi Lu, Xiaofa Qin, Billy Abungu, Anthony Watkins, Francis J Caputo, Da-Zhong Xu, Gregg L Semenza, Edwin A Deitch, Rena Feinman.   

Abstract

Gut injury and loss of normal intestinal barrier function are key elements in the paradigm of gut-origin systemic inflammatory response syndrome, acute lung injury, and multiple organ dysfunction syndrome (MODS). As hypoxia-inducible factor (HIF-1) is a critical determinant of the physiological and pathophysiological response to hypoxia and ischemia, we asked whether HIF-1 plays a proximal role in the induction of gut injury and subsequent lung injury. Using partially HIF-1α-deficient mice in an isolated superior mesenteric artery occlusion (SMAO) intestinal ischemia reperfusion (I/R) injury model (45 min SMAO followed by 3 h of reperfusion), we showed a direct relationship between HIF-1 activation and intestinal I/R injury. Specifically, partial HIF-1α deficiency attenuated SMAO-induced increases in intestinal permeability, lipid peroxidation, mucosal caspase-3 activity, and IL-1β mRNA levels. Furthermore, partial HIF-1α deficiency prevented the induction of ileal mucosal inducible nitric oxide synthase (iNOS) protein levels after SMAO and iNOS deficiency ameliorated SMAO-induced villus injury. Resistance to SMAO-induced gut injury was also associated with resistance to lung injury, as reflected by decreased levels of myeloperoxidase, IL-6 and IL-10 in the lungs of HIF-1α(+/-) mice. In contrast, a short duration of SMAO (15 min) followed by 3 h of reperfusion neither induced mucosal HIF-1α protein levels nor caused significant gut and lung injury in wild-type or HIF-1α(+/-) mice. This study indicates that intestinal HIF-1 activation is a proximal regulator of I/R-induced gut mucosal injury and gut-induced lung injury. However, the duration and severity of the gut I/R insult dictate whether HIF-1 plays a gut-protective or deleterious role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183660      PMCID: PMC3094138          DOI: 10.1152/ajpgi.00459.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  54 in total

1.  Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine.

Authors:  K Y Yeh; M Yeh; J Glass; D N Granger
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

2.  Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes.

Authors:  Marion Scharte; Xiaonan Han; Daniel J Bertges; Mitchell P Fink; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-10-02       Impact factor: 4.052

3.  Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa.

Authors:  Nachiket J Patel; Olga Zaborina; Licheng Wu; Yingmin Wang; Donald J Wolfgeher; Vesta Valuckaite; Mae J Ciancio; Jonathan E Kohler; Olga Shevchenko; Sean P Colgan; Eugene B Chang; Jerrold R Turner; John C Alverdy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-10       Impact factor: 4.052

4.  Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia.

Authors:  Michaël Van Hoecke; Anne S Prigent-Tessier; Philippe E Garnier; Nathalie M Bertrand; Rodolphe Filomenko; Ali Bettaieb; Christine Marie; Alain G Beley
Journal:  Mol Cell Neurosci       Date:  2006-11-13       Impact factor: 4.314

5.  The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes.

Authors:  Grace Vangeison; Dan Carr; Howard J Federoff; David A Rempe
Journal:  J Neurosci       Date:  2008-02-20       Impact factor: 6.167

6.  Inhibition of intestinal ischemia/repurfusion induced apoptosis and necrosis via down-regulation of the NF-kB, c-Jun and caspace-3 expression by epigallocatechin-3-gallate administration.

Authors:  Alexandros E Giakoustidis; Dimitrios E Giakoustidis; Kokona Koliakou; Eleni Kaldrymidou; Stavros Iliadis; Nickolaos Antoniadis; Nicholas Kontos; Vasilios Papanikolaou; Georgios Papageorgiou; Konstantinos Atmatzidis; Dimitrios Takoudas
Journal:  Free Radic Res       Date:  2008-02

7.  Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo.

Authors:  Yanfang Guan; Roger T Worrell; Timothy A Pritts; Marshall H Montrose
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

Review 8.  Hypoxia and gastrointestinal disease.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

9.  Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.

Authors:  Huang-Ping Yu; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  J Leukoc Biol       Date:  2007-06-22       Impact factor: 4.962

10.  Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis.

Authors:  Carole Peyssonnaux; Pilar Cejudo-Martin; Andrew Doedens; Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

View more
  31 in total

Review 1.  Molecular oxygen sensing: implications for visceral surgery.

Authors:  Judit Kiss; Johanna Kirchberg; Martin Schneider
Journal:  Langenbecks Arch Surg       Date:  2012-03-07       Impact factor: 3.445

Review 2.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

Review 3.  Gaseous messengers in oxygen sensing.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  J Mol Med (Berl)       Date:  2012-02-16       Impact factor: 4.599

4.  Intestinal ischemia-reperfusion of macaques triggers a strong innate immune response.

Authors:  Hao Wu; Yi-Yun Deng; Ling Liu; Qing-Hua Tan; Chun-Hui Wang; Mei-Mei Guo; Yong-Mei Xie; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  Inhibition of hypoxia inducible factor-1α ameliorates lung injury induced by trauma and hemorrhagic shock in rats.

Authors:  Hong Jiang; Yan Huang; Hui Xu; Rong Hu; Qi-fang Li
Journal:  Acta Pharmacol Sin       Date:  2012-04-02       Impact factor: 6.150

6.  Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury.

Authors:  Yanwu Jin; Xin Zhao; He Zhang; Qingsong Li; Guodong Lu; Xiaogang Zhao
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

7.  Effects of hyperbaric oxygen on intestinal mucosa apoptosis caused by ischemia-reperfusion injury in rats.

Authors:  Shi-Hui Zhou; Yan-Fei Sun; Gang Wang
Journal:  World J Emerg Med       Date:  2012

8.  GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation.

Authors:  Weidong Xiao; Wensheng Wang; Wei Chen; Lihua Sun; Xiangsheng Li; Chaojun Zhang; Hua Yang
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

9.  Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation.

Authors:  Emily Archer Slone; Michael R Pope; Sherry D Fleming
Journal:  J Leukoc Biol       Date:  2015-07-27       Impact factor: 4.962

10.  Global hypoxia-ischemia induced inflammation and structural changes in the preterm ovine gut which were not ameliorated by mesenchymal stem cell treatment.

Authors:  Maria Nikiforou; Carolin Willburger; Anja E de Jong; Nico Kloosterboer; Reint K Jellema; Daan R M G Ophelders; Harry W M Steinbusch; Boris W Kramer; Tim Wolfs
Journal:  Mol Med       Date:  2016-04-14       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.